Financials

  • Market Capitalization 413.44 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.14
Fiyat/satışlar oranı
26.03

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3054
ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock
14.65 USD-9.40%+10.40%+154.78%-13.98%416.40 M USD
3056
GALT
Galectin Therapeutics Inc. - Common Stock
4.05 USD-2.17%+8.29%+18.08%-3.57%408.44 M USD
3063
FENC
Fennec Pharmaceuticals Inc. - Common Stock
11.77 USD-3.29%+2.97%+17.00%+31.36%412.74 M USD
3071
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.78 USD-4.21%-5.53%+8.88%-0.62%392.18 M USD

Haberler